Recent Financials |
|
|
|
For period ended Dec . 31 , 2017 . |
|
|
|
( CDN $) |
3 Months to December 31 , 2017 |
3 Months to September 30 , 2017 |
Change |
Dispensary cannabis sales ( grams ) 266,182 271,405 ( 2 %)
Average price per gram ( cannabis sales )
$ 15.02 $ 14.94 1 %
Total Revenues $ 4.5M $ 4.4M 2 %
Gross Profit $ 2.6M $ 2.9M ($ 0.3M )
Adjusted EBITDA ($ 1.2M ) ($ 0.3M ) ($ 0.9M )
Net loss ($ 13.0M ) ($ 1.5M ) ($ 11.5M )
Investment Highlights Core Brands
MPX is replicating our successful Arizona operations to expand via organic growth and a roll-up strategy :
• 10 dispensaries in four states ( NV , AZ , MA , MD )
• Well established core brands such as MPX and Health 4 Life
• Well capitalized to run operations and pursue growth opportunities
• Seasoned management team with significant marijuana industry expertise
• License pending in Canada
Contact Info
Tel : 416-840-3725 info @ mpxbioceutical . com
2018 MPX Bioceutical Corporation